<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JULY 14, 2000
REGISTRATION NO. 333-
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
LEXICON GENETICS INCORPORATED
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
<TABLE>
<S> <C>
DELAWARE 76-0474169
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
4000 RESEARCH FOREST DRIVE
THE WOODLANDS, TEXAS 77381
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
</TABLE>
----------------------
2000 EQUITY INCENTIVE PLAN AND
2000 NON-EMPLOYEE DIRECTORS' STOCK OPTION PLAN
(FULL TITLES OF THE PLANS)
----------------------
ARTHUR T. SANDS, M.D., PH.D.
PRESIDENT AND CHIEF EXECUTIVE OFFICER
4000 RESEARCH FOREST DRIVE
THE WOODLANDS, TEXAS 77381
(NAME AND ADDRESS OF AGENT FOR SERVICE)
(281) 364-0100
(TELEPHONE NUMBER, INCLUDING AREA CODE, OF AGENT FOR SERVICE)
----------------------
COPIES TO:
<TABLE>
<S> <C>
JEFFREY R. HARDER JEFFREY L. WADE
ANDREWS & KURTH L.L.P. EXECUTIVE VICE PRESIDENT AND GENERAL COUNSEL
2170 BUCKTHORNE PLACE, SUITE 150 LEXICON GENETICS INCORPORATED
THE WOODLANDS, TEXAS 77380 4000 RESEARCH FOREST DRIVE
(713) 220-4801 THE WOODLANDS, TEXAS 77381
(281) 364-0100
</TABLE>
----------------------
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
==================================================================================================================================
PROPOSED
MAXIMUM PROPOSED
AMOUNT TO OFFERING MAXIMUM
TITLE OF SECURITIES TO BE BE REGISTERED PRICE AGGREGATE AMOUNT OF
REGISTERED TITLE OF PLAN (1) PER SHARE(2) OFFERING PRICE(2) REGISTRATION FEE
----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Common Stock, par value
$0.001 per share ("Common 2000 Equity Incentive 11,250,000 shares $ 41.50 $ 466,875,000 $ 123,288
Stock") Plan
----------------------------------------------------------------------------------------------------------------------------------
2000 Non-Employee
Common Stock Directors' Stock 600,000 shares $ 41.50 $ 24,900,000 $ 6,600
Option Plan
==================================================================================================================================
</TABLE>
(1) Pursuant to Rule 416(a), this registration statement shall cover any
additional securities issued to prevent dilution resulting from stock
splits, stock dividends or similar transactions.
(2) Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457 (c) and (h), based on the average of the high and
low sales price per share of the Registrant's common stock, as reported
on The Nasdaq National Market on July 13, 2000.
================================================================================
<PAGE> 2
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
The following documents filed with the Securities and Exchange
Commission (the "Commission") by the Registrant are incorporated by reference in
this Registration Statement:
(a) The Registrant's prospectus filed pursuant to Rule 424(b)
under the Securities Act of 1933, as amended (the "Securities
Act"), on April 7, 2000, in connection with the Registration
Statement on Form S-1, as amended (No. 333-96469), originally
filed on February 9, 2000;
(b) The Registrant's Quarterly Report on Form 10-Q for the quarter
ended March 31, 2000; and
(c) The description of the common stock, par value $0.001 per
share (the "Common Stock"), of the Registrant contained in the
Registrant's Registration Statement on Form 8-A filed with the
Commission on March 27, 2000 pursuant to Section 12 of the
Securities Exchange Act of 1934, as amended (the "Exchange
Act"), including any amendments and reports filed for the
purpose of updating such description.
All documents subsequently filed by the Registrant pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a
post-effective amendment which indicates that all shares of Common Stock offered
hereby have been sold or which deregisters all shares of Common Stock then
remaining unsold, shall be deemed to be incorporated by reference herein and to
be part hereof from the date of the filing of such documents. Any statement
contained in a document incorporated or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for purposes of this
Registration Statement to the extent that a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated
by reference herein modifies or supersedes such statement. Any statement so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Registration Statement.
ITEM 4. DESCRIPTION OF SECURITIES.
The information required by Item 4 is not applicable to this
registration statement because the class of securities to be offered is
registered under Section 12 of the Exchange Act.
ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.
The information required by Item 5 is not applicable to this
registration statement.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Section 145 of the Delaware General Corporation Law ("DGCL") provides
that a corporation may indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed action,
suit or proceeding whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation by reason of the
fact that he is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, against expenses (including attorneys'
fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by him in connection with such action, suit or proceeding if he acted
in good faith and in a manner he reasonably believed to be in or not opposed to
the best interests of the corporation, and, with respect to any criminal action
or proceeding, had no reasonable cause to believe his conduct was unlawful.
Section 145 further provides that a corporation similarly may indemnify any such
person serving in any such capacity who was or is a party or is threatened to be
made a party to any threatened, pending or completed action or suit by or in the
right of the corporation to procure a judgment in its favor by reason of the
fact that he is or was a director, officer, employee or agent of the corporation
or is or was serving at the request of the corporation as a director, officer,
employee or agent of
II-1
<PAGE> 3
another corporation, partnership, joint venture, trust or other enterprise,
against expenses (including attorneys' fees) actually and reasonably incurred in
connection with the defense or settlement of such action or suit if he acted in
good faith and in a manner he reasonably believed to be in or not opposed to the
best interests of the corporation and except that no indemnification shall be
made in respect of any claim, issue or matter as to which such person shall have
been adjudged to be liable to the corporation unless and only to the extent that
the Delaware Court of Chancery or such other court in which such action or suit
was brought shall determine upon application that, despite the adjudication of
liability but in view of all of the circumstances of the case, such person is
fairly and reasonably entitled to indemnity for such expenses which the Delaware
Court of Chancery or such other court shall deem proper.
The Registrant's certificate of incorporation and bylaws provide that
indemnification shall be to the fullest extent permitted by the DGCL for all
current or former directors or officers. As permitted by the DGCL, the
certificate of incorporation provides that directors of the Registrant shall
have no personal liability to the Registrant or its stockholders for monetary
damages for breach of fiduciary duty as a director, except (1) for any breach of
the director's duty of loyalty to the Registrant or its stockholders, (2) for
acts or omissions not in good faith or which involve intentional misconduct or
knowing violation of law, (3) under Section 174 of the DGCL or (4) for any
transaction from which a director derived an improper personal benefit.
The Registrant has entered into indemnification agreements with each of
its officers and directors. Each such agreement provides that each party to the
agreement shall have no personal liability to the Registrant or its stockholders
for monetary damages for breach of fiduciary duty as a director, except (1) for
any breach of the director's duty of loyalty to the Registrant or its
stockholders, (2) for acts or omissions not in good faith or which involve
intentional misconduct or knowing violation of law, (3) under Section 174 of the
DGCL or (4) for any transaction from which a director derived an improper
personal benefit. Each such agreement also provides an indemnification to each
party to the agreement against damages and expenses arising from claims against
such party for a breach of such party's fiduciary duty to the Registrant or its
stockholders.
ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.
The information required by Item 7 is not applicable to this
registration statement.
ITEM 8. EXHIBITS.
EXHIBIT
NUMBER DESCRIPTION
------ -----------
4.1+ Restated Certificate of Incorporation (incorporated by
reference to Exhibit 3.1 to the Registrant's Registration
Statement on Form S-1 (No. 333-96469), originally filed on
February 9, 2000 (the "Registration Statement")).
4.2+ Restated Bylaws (incorporated by reference to Exhibit 3.2 to
the Registration Statement).
5.1* Opinion of Andrews & Kurth L.L.P.
23.1* Consent of Andrews & Kurth L.L.P. (included in Exhibit 5.1).
23.2* Consent of Arthur Andersen LLP
24.1* Power of Attorney (set forth on the signature page contained in
Part II of this Registration Statement).
99.1+ Lexicon Genetics Incorporated 2000 Equity Incentive Plan
(incorporated by reference to Exhibit 10.7 to the Registration
Statement).
II-2
<PAGE> 4
99.2+ Lexicon Genetics Incorporated Non-Employee Directors' Stock
Option Plan (incorporated by reference to Exhibit 10.8 to the
Registration Statement).
--------------------------
+ Incorporated herein by reference.
* Filed herewith.
ITEM 9. UNDERTAKINGS.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration statement:
(i) To include any prospectus required by Section
10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of this registration
statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in this
registration statement;
(iii) To include any material information with
respect to the plan of distribution not previously disclosed
in this registration statement or any material change to such
information in this registration statement;
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) above do
not apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in periodic
reports filed by the Registrant pursuant to Section 13 or Section 15(d)
of the Exchange Act that are incorporated by reference in the
registration statement.
(2) That, for the purpose of determining any liability under
the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at
the termination of the offering.
(b) The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Exchange Act, each filing of the
Registrant's annual report pursuant to Section 13(a) or 15(d) of the Exchange
Act that is incorporated by reference in this Registration Statement shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
II-3
<PAGE> 5
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in The Woodlands, in the
State of Texas, on July 14, 2000.
LEXICON GENETICS INCORPORATED
By: /s/ ARTHUR T. SANDS, M.D., PH.D.
---------------------------------
Arthur T. Sands, M.D., Ph.D.,
President and Chief Executive Officer
POWER OF ATTORNEY
The person whose signature appears below appoints Arthur T. Sands,
M.D., Ph.D., Julia P. Gregory and Jeffrey L. Wade, and each of them, any of whom
may act without the joinder of the other, as his true and lawful
attorneys-in-fact and agents with full power of substitution and resubstitution,
for him and in his name, place and stead, in any and all capacities, to sign any
and all amendments (including post-effective amendments) to this Registration
Statement and any Registration Statement (including any amendment thereto) for
this offering that is to be effective upon filing pursuant to Rule 462(b) under
the Securities Act of 1933, as amended, and to file the same, with all exhibits
thereto, and all other documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorneys-in-fact and agents full
power and authority to do and perform each and every act and thing requisite and
necessary to be done, as fully to all intents and purposes as he might or would
do in person, hereby ratifying and confirming all that said attorneys-in-fact
and agents or any of them or their or his substitute and substitutes, may
lawfully do or cause to be done by virtue hereof.
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, AS AMENDED,
THIS REGISTRATION STATEMENT HAS BEEN SIGNED BELOW BY THE FOLLOWING PERSONS IN
THE CAPACITIES AND ON THE DATES INDICATED BELOW.
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/ ARTHUR T. SANDS, M.D., PH.D. President, Chief Executive July 14, 2000
-------------------------------- Officer and Director
Arthur T. Sands, M.D., Ph.D. (principal executive officer)
/s/ JULIA P. GREGORY Executive Vice President and July 14, 2000
-------------------- Chief Financial Officer
Julia P. Gregory (principal financial and
accounting officer)
/s/ THOMAS CASKEY, M.D. Chairman of the Board of July 14, 2000
----------------------- Directors
Thomas Caskey, M.D.
/s/ STEPHEN J. BANKS Director July 14, 2000
--------------------
Stephen J. Banks
</TABLE>
II-4
<PAGE> 6
<TABLE>
<S> <C> <C>
/s/ SAM L. BARKER, Ph.D. Director July 14, 2000
------------------------
Sam L. Barker, Ph.D.
/s/ GORDON A. CAIN Director July 14, 2000
------------------
Gordon A. Cain
/s/ PATRICIA M. CLOHERTY Director July 14, 2000
------------------------
Patricia M. Cloherty
/ / Director July 14, 2000
---------------------
Paul Haycock, M.D.
/s/ WILLIAM A. McMINN Director July 14, 2000
---------------------
William A. McMinn
</TABLE>
II-5
<PAGE> 7
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------ -----------
4.1+ Restated Certificate of Incorporation (incorporated by
reference to Exhibit 3.1 to the Registrant's Registration
Statement on Form S-1 (No. 333-96469), originally filed on
February 9, 2000 (the "Registration Statement")).
4.2+ Restated Bylaws (incorporated by reference to Exhibit 3.2 to
the Registration Statement).
5.1* Opinion of Andrews & Kurth L.L.P.
23.1* Consent of Andrews & Kurth L.L.P. (included in Exhibit 5.1).
23.2* Consent of Arthur Andersen LLP
24.1* Power of Attorney (set forth on the signature page contained in
Part II of this Registration Statement).
99.1+ Lexicon Genetics Incorporated 2000 Equity Incentive Plan
(incorporated by reference to Exhibit 10.7 to the Registration
Statement).
99.2+ Lexicon Genetics Incorporated Non-Employee Directors' Stock
Option Plan (incorporated by reference to Exhibit 10.8 to the
Registration Statement).
----------------------------
+ Incorporated herein by reference.
* Filed herewith.
